About Srisukipharma Private Limited
Data last updated:
Srisukipharma Private Limited is a private limited company based in Vellore, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 09 October 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U74999TN2018PTC125182. Its GSTIN is 33ABACS9756P1ZL (Tamil Nadu).
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹78.85 Lakh. It is led by directors including Balaji Nandagopal and Shanthi Balaji.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Vellore, Tamil Nadu.
As per the financials filed for FY 2024, the company reported a revenue of ₹4.02 Cr, a growth of 79% compared to the previous year. For the same year it recorded a net profit of ₹1.39 Lakh (net margin 0.3%) and EBITDA of ₹1.65 Lakh (EBITDA margin 0.4%). Revenue has grown at a compounded annual rate (CAGR) of 28% over three years.
For more details, the company can be reached via its website srisukipharma.com.
Company details
Contact details
Srisukipharma Private Limited's registered office is in Vellore, Tamil Nadu. Its website is srisukipharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot Nos. 20&21 Sf No. 110/2 3rd Floor, Pennathur Road Ariyur, Vellore, Tamil Nadu, India – 632055
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Srisukipharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Srisukipharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Srisukipharma Private Limited, buy the company report.
Financials of Srisukipharma Private Limited
FY 2024 filings availableSrisukipharma Private Limited reported revenue of ₹4.02 Cr (up 79% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 28% over three years, including 79% growth in the latest year. EBITDA fell 80% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.65 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.39 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.4% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Srisukipharma Private Limited, buy the company report.
Board of directors of Srisukipharma Private Limited
Srisukipharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Balaji Nandagopal | Director | 09 Oct 2018 | 8 Years 0 Months | Current |
| Shanthi Balaji | Director | 09 Oct 2018 | 8 Years 0 Months | Current |
| Ho Linfo Also directs: Srisuki Promoters and Developers Private Limited | Director | 31 Jul 2019 | 7 Years 2 Months | Current |
Peer comparison
Srisukipharma Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Brisc Healthcare Private Limited | ₹4.02 Cr (FY 2025) | 3.0% | Delhi, India | |||
| Srisukipharma Private Limitedthis company | ₹4.02 Cr (FY 2024) | ₹1.39 Lakh | 0.3% | 79.0% | Vellore, Tamil Nadu, India | |
| Ezyspit Solutions Private Limited | ₹4.02 Cr (FY 2022) | 1429.0% | Maratha Hotel Nagpur, Maharashtra, India | |||
| Algen Remedies Private Limited | ₹4.01 Cr (FY 2025) | 11.0% | New Delhi, Delhi, India | |||
| Verlen Labs Private Limited | ₹4.01 Cr (FY 2024) | -18.0% | Secunderabad, Telangana, India | |||
| Amraph India Private Limited | ₹4.01 Cr (FY 2024) | 31.0% | New Delhi, Delhi, India | |||
| Chiron Pharmaceuticals Private Limited | ₹4 Cr (FY 2024) | 11.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Srisukipharma Private Limited, buy the company report.
Shareholding
The shareholding of Srisukipharma Private Limited is on record for 2 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Srisukipharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Srisukipharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Srisukipharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Srisukipharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33ABACS9756P1ZL | Tamil Nadu | Active | 27 Jun 2019 |
To see the full GST registrations and return filing status of Srisukipharma Private Limited, buy the company report.
Recent activity
Srisukipharma Private Limited has 4 board changes on record since 2018: 3 appointments and 1 cessation. The latest: Ho Linfo ceased to be Additional Director on 20 Nov 2019.
Frequently asked questions
Srisukipharma is an active private limited company based in Vellore, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 09 October 2018 (8+ years old) and is registered under CIN U74999TN2018PTC125182.
Srisukipharma has 3 current directors:
- Balaji Nandagopal - Director
- Shanthi Balaji - Director
- Ho Linfo - Director
The latest financial statements of Srisukipharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Srisukipharma is 33ABACS9756P1ZL, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Srisukipharma is U74999TN2018PTC125182. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Srisukipharma was incorporated on 09 October 2018, making it 8+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Srisukipharma by revenue are Brisc Healthcare Private Limited, Ezyspit Solutions Private Limited, Algen Remedies Private Limited, Verlen Labs Private Limited, Amraph India Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Ho Linfo ceased to be Additional Director on 20 Nov 2019. Ho Linfo was appointed as Director on 31 Jul 2019. Balaji Nandagopal was appointed as Director on 09 Oct 2018. Srisukipharma has 4 board changes on record in total.
Srisukipharma can be reached through the website srisukipharma.com. Its registered office is in Vellore, Tamil Nadu, India.
The registered office of Srisukipharma is at Plot Nos. 20&21 Sf No. 1102 3rd Floor, Pennathur Road Ariyur, Vellore, Tamil Nadu, India – 632055.
Srisukipharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.